CTSB and cancer: We now findthat ANA nuclear penetration induces nuclear flux by the lysosomalprotease cathepsin B. This discovery facilitates design of a tumoragnostic antinuclear antibody−drug conjugate (ANADC) that targetsnucleic acid exhaust from necrotic tumors as a DNA-seeking “antinuclearmissile” cancer therapy.